tm logo
ULTRASOLUTE
Live/Registered
REGISTERED

on 18 Apr 2023

Last Applicant/ Owned by

Prins de Lignestraat 28

Geleen

NL

NL-6161CZ

Serial Number

97349308 filed on 06th Apr 2022

Registration Number

7032696 registered on 18th Apr 2023

in the Principal Register

Correspondent Address

Nancy E. Wolff

COWAN DEBAETS ABRAHAMS & SHEPPARD LLP

41 MADISON AVENUE, 38TH FLOOR

NEW YORK, NY 10010

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ULTRASOLUTE

Chemical reagents for medical purposes; reagents for in-vitro laboratory use for medical purposes; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical use; diagnostic reagents and contrast media for medical use; in-vitro ovulation prediction test kit for home use; in vitro gender prediction test kit; cryopreservation kits for use in in vitro fertilization conRead More

Classification Information


Class [005]
Pharmaceutical Products


Chemical reagents for medical purposes; reagents for in-vitro laboratory use for medical purposes; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical use; diagnostic reagents and contrast media for medical use; in-vitro ovulation prediction test kit for home use; in vitro gender prediction test kit; cryopreservation kits for use in in vitro fertilization consisting primarily of sperm freezing medium, in vitro fertilization medium, sperm freezing canister, cans for holding straws filled with semen, and mixing tubes; in vitro test kits to diagnose diabetes, viral diseases, bacteria-based diseases, eye diseases, bone diseases, kidney diseases, autoimmune diseases, cancer, heart rhythm disorders, heart failure, cystic fibrosis, neurodegenerative diseases, epileptic disorders, neurodegenerative diseases; fertility enhancement preparations; greases for medical purposes; cell growth media for growing cells for medical or clinical use; caustics for pharmaceutical purposes; antibacterial pharmaceutical; vaccines; vaccine preparations; pharmaceutical products for the treatment of diabetes, viral diseases, bacteria-based diseases, eye diseases, bone diseases, kidney diseases, autoimmune diseases, cancer, heart rhythm disorders, heart failure, cystic fibrosis, neurodegenerative diseases; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for peripheral nervous system; anti-epileptic pharmaceutical preparations


First Use Date in General

27th Apr 2022

First Use Date in Commerce

27th Apr 2022

Class [001]
Chemical Products


Chemicals for use in industry and science; chemicals for use in biotechnological manufacturing processes; chemical reagents for non-medical purposes; diagnostic reagents for scientific or research use; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; reagents for research purposes; adhesives for industrial purposes; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemicals for use in the purification of proteins for in vitro use; chemical additives for use in the manufacture of pharmaceuticals; cell growth media for growing cells for scientific and research use


First Use Date in General

27th Apr 2022

First Use Date in Commerce

27th Apr 2022

Mark Details


Serial Number

No 97349308

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 2035.18

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Apr 2023REGISTERED-PRINCIPAL REGISTER
18th Apr 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
15th Mar 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
14th Mar 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07th Mar 2023STATEMENT OF USE PROCESSING COMPLETE
06th Mar 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
17th Feb 2023USE AMENDMENT FILED
17th Feb 2023TEAS STATEMENT OF USE RECEIVED
15th Nov 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
20th Sep 2022PUBLISHED FOR OPPOSITION